Source:http://linkedlifedata.com/resource/pubmed/id/16769253
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2006-9-19
|
pubmed:abstractText |
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) published its main findings in December, 2002. It recommended thiazide diuretics as a first-line treatment of hypertension. The current study describes the prescribing patterns of thiazide diuretics in four regions of Kaiser Permanente, a large national United States Health Maintenance Organization--two regions that had an ALLHAT clinical center and two that did not. We tested the hypothesis that participation in a clinical trial leads to quicker and greater adoption of study recommendations than non-participation in a trial. The relative percentage of filled outpatient prescriptions for the period 2 or 3 years before the ALLHAT main publication through December 31, 2004 was calculated by region for thiazide-type diuretics and for calcium channel blockers (CCBs), beta-blockers, central alpha-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) and other antihypertensive diuretics. In the 2 years after publication of the ALLHAT trial findings, the percentage of all prescriptions for thiazide diuretics increased from 11.2% to 12.4% in the two regions with an ALLHAT clinical site and from 8.9% to 10.1% in the two regions without an ALLHAT clinical site (p > 0.05). The percentage of new prescriptions for thiazide diuretics increased from 13.7% to 16.6% in the two regions with an ALLHAT clinical site and from 10.8% to 13.0% in the two regions without an ALLHAT clinical site (p > 0.05). Participation in a clinical hypertension study does not appear to accelerate adoption of study recommendations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1551-7144
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
397-403
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16769253-Antihypertensive Agents,
pubmed-meshheading:16769253-Clinical Trials as Topic,
pubmed-meshheading:16769253-Diffusion of Innovation,
pubmed-meshheading:16769253-Drug Prescriptions,
pubmed-meshheading:16769253-Female,
pubmed-meshheading:16769253-Health Maintenance Organizations,
pubmed-meshheading:16769253-Humans,
pubmed-meshheading:16769253-Hypertension,
pubmed-meshheading:16769253-Male,
pubmed-meshheading:16769253-Middle Aged,
pubmed-meshheading:16769253-Physician's Practice Patterns,
pubmed-meshheading:16769253-Sodium Chloride Symporter Inhibitors,
pubmed-meshheading:16769253-United States
|
pubmed:year |
2006
|
pubmed:articleTitle |
Prescribing patterns for thiazide diuretics in a large health maintenance organization: relationship to participation as an ALLHAT clinical center.
|
pubmed:affiliation |
Kaiser Permanente Southern California, 393 E. Walnut Street, Pasadena, 91188, USA. Diana.b.petitti@kp.org
|
pubmed:publicationType |
Journal Article
|